XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation
The reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:
 Year Ended December 31,
 20222021
Federal statutory income tax rate21.0 %21.0 %
Federal and state research and development credits3.7 %3.8 %
State taxes, net of federal benefit4.2 %4.8 %
Non-deductible items(0.7)%(1.7)%
Stock-based compensation(1.0)%1.6 %
Change in valuation allowance(27.2)%(29.4)%
Other— %(0.1)%
Effective income tax rate— %— %
Schedule of Deferred Tax Assets and Liabilities
Net deferred tax assets consisted of the following (in thousands):
 December 31,
 20222021
Deferred tax assets:
Net operating loss carryforwards$60,047 $56,482 
Capitalized research expenditures34,947 — 
Amortization24,262 14,295 
Research and development credits17,205 9,296 
Stock-based compensation6,422 3,759 
Leases898 1,132 
Accrued expenses893 1,952 
Total gross deferred tax assets$144,674 $86,916 
Less: Valuation allowance(143,930)(85,957)
Net deferred tax assets$744 $959 
Deferred tax liabilities:
Operating lease right-of-use asset(744)(959)
Total gross deferred tax liabilities(744)(959)
Net deferred tax assets$— $—